• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症中生长激素分泌的调节:每日生长激素谱的可重复性及胰岛素样生长因子-I负反馈减弱

Regulation of GH secretion in acromegaly: reproducibility of daily GH profiles and attenuated negative feedback by IGF-I.

作者信息

Jaffe C A, Pan W, Brown M B, DeMott-Friberg R, Barkan A L

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Michigan Medical Center, University of Michigan, Ann Arbor, Michigan 48109, USA.

出版信息

J Clin Endocrinol Metab. 2001 Sep;86(9):4364-70. doi: 10.1210/jcem.86.9.7840.

DOI:10.1210/jcem.86.9.7840
PMID:11549676
Abstract

GH hypersecretion is a hallmark of acromegaly. It is unknown whether the secretory activity of somatotroph adenoma is autonomous or is still governed by central or peripheral mechanisms. In this study we investigated whether GH secretion in acromegaly 1) has a reproducible circadian pattern and 2) is inhibited by exogenous IGF-I. Eleven patients with newly diagnosed acromegaly were studied in 2 protocols. In protocol 1, peripheral blood was sampled every 10 min for 48 h in 6 patients for the determination of concordance between 24-h GH profiles. There was no significant day to day variability in mean 24-h output. There was, however, a significant time effect, and the 24-h GH secretion pattern was maintained between days. In protocol 2, 5 patients were sampled for GH every 10 min twice, once during infusion of normal saline and once during iv infusion of recombinant human IGF-I (10 microg/kg x h). The recombinant human IGF-I infusion increased plasma IGF-I to approximately 230% of the baseline concentration. This resulted in GH suppression (4220 +/- 1950 vs. 3223 +/- 1472 microg/liter.min; P = 0.001), but did not alter GH secretion pattern. There were highly significant cross-correlations for 10 of the 11 of the subjects in the two protocols when the lag was 0 min. By harmonic analysis, nocturnal augmentation of GH was maintained, and maximum daily GH occurred at approximately 2300 h. These data demonstrate that the pattern of GH secretion in acromegaly is not random, but is highly preserved with 24-h periodicity. In addition, negative feedback regulation by IGF-I is preserved, although the degree of negative feedback is grossly attenuated. Thus, secretory activity of somatotroph adenomas is not autonomous or haphazard, but is still subject to both feedback and feedforward regulatory mechanisms.

摘要

生长激素分泌过多是肢端肥大症的一个标志。目前尚不清楚生长激素腺瘤的分泌活动是自主性的,还是仍受中枢或外周机制的调控。在本研究中,我们调查了肢端肥大症患者的生长激素分泌情况:1)是否具有可重复的昼夜节律模式;2)是否受外源性胰岛素样生长因子-I(IGF-I)抑制。11例新诊断的肢端肥大症患者参与了2项研究方案。在方案1中,6例患者每10分钟采集一次外周血,共采集48小时,以确定24小时生长激素谱之间的一致性。24小时平均分泌量无显著的每日变化。然而,存在显著的时间效应,且24小时生长激素分泌模式在不同日期之间保持稳定。在方案2中,5例患者每10分钟采集一次生长激素样本,共采集两次,一次在输注生理盐水期间,一次在静脉输注重组人生长激素-I(10微克/千克·小时)期间。重组人生长激素-I输注使血浆IGF-I升高至基线浓度的约230%。这导致生长激素分泌受到抑制(4220±1950对3223±1472微克/升·分钟;P = 0.001),但未改变生长激素分泌模式。当延迟为0分钟时,两项研究方案中11名受试者中的10名存在高度显著的交叉相关性。通过谐波分析,生长激素的夜间分泌增加得以维持,且每日生长激素分泌峰值出现在约23:00。这些数据表明,肢端肥大症患者的生长激素分泌模式并非随机,而是以24小时周期高度保持稳定。此外,尽管负反馈程度明显减弱,但IGF-I的负反馈调节仍然存在。因此,生长激素腺瘤的分泌活动并非自主性或随意性的,而是仍受反馈和前馈调节机制的影响。

相似文献

1
Regulation of GH secretion in acromegaly: reproducibility of daily GH profiles and attenuated negative feedback by IGF-I.肢端肥大症中生长激素分泌的调节:每日生长激素谱的可重复性及胰岛素样生长因子-I负反馈减弱
J Clin Endocrinol Metab. 2001 Sep;86(9):4364-70. doi: 10.1210/jcem.86.9.7840.
2
The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.经成功治疗的肢端肥大症患者24小时生长激素分泌与胰岛素样生长因子I之间的关系:手术或放疗的影响
J Clin Endocrinol Metab. 2001 Jan;86(1):259-66. doi: 10.1210/jcem.86.1.7154.
3
Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly.正常人和肢端肥大症患者禁食对脉冲式生长激素分泌的调节。
J Clin Endocrinol Metab. 1992 Sep;75(3):812-9. doi: 10.1210/jcem.75.3.1517371.
4
The control on growth hormone release by free fatty acids is maintained in acromegaly.在肢端肥大症中,游离脂肪酸对生长激素释放的控制仍然存在。
J Clin Endocrinol Metab. 1999 Apr;84(4):1234-8. doi: 10.1210/jcem.84.4.5618.
5
Hormonal diagnosis of GH hypersecretory states.生长激素分泌过多状态的激素诊断。
J Endocrinol Invest. 2003;26(10 Suppl):27-35.
6
Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.连续24小时静脉输注重组人生长激素释放激素(1-44)酰胺,在绝经后女性处于雌激素缺乏和雌激素补充状态时,均能增强脉冲式、熵性和每日节律性生长激素分泌。
J Clin Endocrinol Metab. 2001 Feb;86(2):700-12. doi: 10.1210/jcem.86.2.7195.
7
The role of endogenous growth hormone-releasing hormone in acromegaly.内源性生长激素释放激素在肢端肥大症中的作用。
J Clin Endocrinol Metab. 2006 Jun;91(6):2185-90. doi: 10.1210/jc.2005-2398. Epub 2006 Mar 14.
8
Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.男性青春期中期生长激素(GH)自身负反馈的加速逃逸:青春期男孩中GH诱导的生长抑素能流出存在时间限制的证据。
J Clin Endocrinol Metab. 2002 Aug;87(8):3837-44. doi: 10.1210/jcem.87.8.8770.
9
Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.口服葡萄糖后 GH 水平和 IGF-I 水平不一致,且肢端肥大症患者经治疗后 GH 水平降低:轻度疾病活动的生化标志物的精细化。
Horm Metab Res. 2010 Jan;42(1):50-5. doi: 10.1055/s-0029-1239522. Epub 2009 Oct 1.
10
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.重组人胰岛素样生长因子I给药对人体生长激素(GH)分泌的影响,包括自发分泌以及由生长激素释放激素或六肽促生长激素释放肽(一种肽类GH促分泌素)刺激后的分泌。
J Clin Endocrinol Metab. 1999 Jan;84(1):285-90. doi: 10.1210/jcem.84.1.5386.

引用本文的文献

1
Tamoxifen as a therapeutic agent in acromegaly.他莫昔芬在肢端肥大症治疗中的应用。
Pituitary. 2014 Dec;17(6):500-4. doi: 10.1007/s11102-013-0534-9.
2
Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas.肢端肥大症患者的生长激素分泌具有复杂的节律性和年龄依赖性:进一步证明下丘脑对垂体生长激素瘤具有控制作用。
J Clin Endocrinol Metab. 2013 Jul;98(7):2959-66. doi: 10.1210/jc.2013-1581. Epub 2013 May 2.
3
Estrogen treatment for acromegaly.
肢端肥大症的雌激素治疗。
Pituitary. 2012 Dec;15(4):601-7. doi: 10.1007/s11102-012-0426-4.
4
Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration?垂体 MRI 阴性且无异位源证据的肢端肥大症:经蝶窦垂体探查的作用?
Pituitary. 2011 Dec;14(4):414-7. doi: 10.1007/s11102-009-0205-z.